L

LYEL

LYEL

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
LYEL Live QuoteReal-time
$13.58
+$4.17(+44.31%)1M
Day Range$13.38 – $13.98
Open$13.74
Previous Close$13.89
Volume144.2K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$444.70M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-12.61
Price to Book2.3
Dividend Yield0.65%
Beta (Volatility)-0.09
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $13.58 (17%)
Low: $7.20High: $45.00
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$37.62-74.9% upside

Insider Buys

2

$50.00M

Insider Sales

0

$0

Total Volume

$50.00M

2 transactions

Net Activity

+$50.00M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
90CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
A
1

Arch Venture Partners Ix, LLC

10%

1 buys0 sells

$25.00M total

A
2

Arch Venture Fund Xiii, L.P.

10%

1 buys0 sells

$25.00M total

Trading History
LYEL insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 4, 2026

2 weeks ago

Arch Venture Partners Ix, LLC

10%

10% Owner
Buy2.32M$10.77$25.00M

Nov 4, 2026

2 weeks ago

Arch Venture Fund Xiii, L.P.

10%

10% Owner
Buy2.32M$10.77$25.00M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
LYEL Buy Conviction100%
Industry Rank#37 of 569
Volume Contribution0.3%
Total Industry Activity$16.53B

LYEL has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. LYEL ranks #37 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for LYEL

Over the last 90 days, corporate insiders at LYEL (LYEL) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $50.00M.

The net insider activity for LYEL shows a net buying bias of $50.00M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Arch Venture Partners Ix, LLC (10%), who traded 2.32M shares valued at $25.00M on Nov 4, 2026.

Live Market News & Developments
Aggregated real-time headlines for LYEL (LYEL)
6 updates

Lyell Immunopharma, Inc. (LYEL) Stock Price, News, Quote & History

Yahoo! Finance Canada3d ago

Lyell Immunopharma Stock Price Forecast. Should You Buy LYEL?

StockInvest.us4d ago

Lyell Immunopharma, Inc. (LYEL) stock price, news, quote and history

Yahoo Finance UKYesterday

LYEL - Lyell Immunopharma Inc Stock Price and Quote

Finviz177d ago

(LYEL) Risk Channels and Responsive Allocation

Stock Traders Daily2d ago

An approximately $80 million stock sale is expected to help fund Lyell's cancer trials into 2028.

Stock Titan16d ago

FAQs About LYEL Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for LYEL.

Based on SEC Form 4 disclosures, the Insider Confidence Score for LYEL is currently 90/100, which reflects a strong accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for LYEL is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.